AI English summary of an SEC filing — figures as filed
IQVIA IQVThe company said its Q3 2026 revenue rose $328 million (8.0%) from a year earlier, and its revenue for the first 9 months rose $1,001 million (8.4%). Constant currency growth for Q3 was approximately $353 million (8.6%).
Key points
AI summaryThe company said its Q3 2026 revenue rose $328 million (8.0%) from a year earlier, and its revenue for the first 9 months rose $1,001 million (8.4%). Constant currency growth for Q3 was approximately $353 million (8.6%).
IQVIA said it reorganized its reportable segments into two, Commercial Solutions and Research & Development Solutions, effective January 1, 2026. Revenue for Q3 was $1,789 million at Commercial Solutions and $2,639 million at Research & Development Solutions.
The company said the contracted backlog at Research & Development Solutions changed from $34.0 billion as of December 31, 2025 (recast to reflect the segment changes) to $32.6 billion as of September 30, 2026. It expects about $9.4 billion of this backlog to convert to revenue in the next 12 months. The company also said that after refining its backlog assessment criteria for inactive trials, the backlog was reduced by $2.1 billion.
The company said it issued $2,000 million in 6.375% senior notes due 2034 on September 23, 2026. It said it used the proceeds to place funds in escrow for redemption and discharge of the 5.0% Notes, to repay part of its revolving credit facility borrowings, and to pay issuance costs.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Q3 2026 and 9-Month Revenue Growth
The company said its Q3 2026 revenue rose $328 million (8.0%) from a year earlier, and its revenue for the first 9 months rose $1,001 million (8.4%). Constant currency growth for Q3 was approximately $353 million (8.6%).
Source · Based on the MD&A text of the filing
Segment Restructuring and Segment Revenue in Q3
IQVIA said it reorganized its reportable segments into two, Commercial Solutions and Research & Development Solutions, effective January 1, 2026. Revenue for Q3 was $1,789 million at Commercial Solutions and $2,639 million at Research & Development Solutions.
Source · Based on the MD&A text of the filing
Additional Information
The company said the contracted backlog at Research & Development Solutions changed from $34.0 billion as of December 31, 2025 (recast to reflect the segment changes) to $32.6 billion as of September 30, 2026. It expects about $9.4 billion of this backlog to convert to revenue in the next 12 months. The company also said that after refining its backlog assessment criteria for inactive trials, the backlog was reduced by $2.1 billion.
Source · Based on the MD&A text of the filing
Q3 2026 $2,000 million Senior Notes Offering
The company said it issued $2,000 million in 6.375% senior notes due 2034 on September 23, 2026. It said it used the proceeds to place funds in escrow for redemption and discharge of the 5.0% Notes, to repay part of its revolving credit facility borrowings, and to pay issuance costs.
Source · Based on the MD&A text of the filing
Structured SEC financial data for this filing is not available yet. Please check the figures in the SEC filing.
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…